OOIR: Observatory of International Research

Papers

(The median citation count of Therapeutic Advances in Musculoskeletal Disease is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)

Article	Citations
Hydroxychloroquine in systemic lupus erythematosus: overview of current knowledge	49
Pathophysiology of musculoskeletal pain: a narrative review	40
Promising targets for therapy of osteoarthritis: a review on the Wnt and TGF-β signalling pathways	32
Psoriatic arthritis and the association with cardiometabolic disease: a narrative review	31
Axial Involvement in Psoriatic Arthritis cohort (AXIS): the protocol of a joint project of the Assessment of SpondyloArthritis international Society (ASAS) and the Group for Research and Assessment of	30
Osteoporosis in 10 years time: a glimpse into the future of osteoporosis	29
Role of autoantibodies in the diagnosis and prognosis of interstitial lung disease in autoimmune rheumatic disorders	29
Opportunistic diagnosis of osteoporosis, fragile bone strength and vertebral fractures from routine CT scans; a review of approved technology systems and pathways to implementation	25
A warning machine learning algorithm for early knee osteoarthritis structural progressor patient screening	24
Body composition in patients with rheumatoid arthritis: a narrative literature review	24
Moving toward targeting the right phenotype with the right platelet-rich plasma (PRP) formulation for knee osteoarthritis	23
Comparative effectiveness of treatment options for subacromial shoulder conditions: a systematic review and network meta-analysis	18
Natural history and screening of interstitial lung disease in systemic autoimmune rheumatic disorders	18
A broad look into the future of rheumatoid arthritis	18
Is central sensitization an important determinant of functional disability in patients with chronic inflammatory arthritides?	18
Immunogenicity and safety of inactivated and mRNA COVID-19 vaccines in patients with systemic lupus erythematosus	18
Repurposed and investigational disease-modifying drugs in osteoarthritis (DMOADs)	17
Large-vessel involvement is predictive of multiple relapses in giant cell arteritis	17
Hospital admissions in inflammatory rheumatic diseases during the peak of COVID-19 pandemic: incidence and role of disease-modifying agents	17
Biomarkers predictive of treatment response in psoriasis and psoriatic arthritis: a systematic review	17
Infigratinib in children with achondroplasia: the PROPEL and PROPEL 2 studies	16
Non-steroidal anti-inflammatory drugs in the pharmacological management of osteoarthritis in the very old: prescribe or proscribe?	15
Hyperuricemia, urate-lowering therapy, and kidney outcomes: a systematic review and meta-analysis	15
A glimpse into the future of systemic lupus erythematosus	14
Comparative efficacy and safety of Janus kinase inhibitors and biological disease-modifying antirheumatic drugs in rheumatoid arthritis: a systematic review and network meta-analysis	14

Ultrasound for diagnosis and follow-up of chronic axillary vasculitis in patients with long-standing giant cell arteritis	14
The value of anti-CarP and anti-PAD4 as markers of rheumatoid arthritis in ACPA/RF negative rheumatoid arthritis patients	14
Prevalence of axial spondyloarthritis in patients with inflammatory bowel disease using cross-sectional imaging: a systematic literature review	13
Cycling of tumor necrosis factor inhibitors versus switching to different mechanism of action therapy in rheumatoid arthritis patients with inadequate response to tumor necrosis factor inhibito	13
Intramuscular neridronate for the treatment of complex regional pain syndrome type 1: a randomized, double-blind, placebo-controlled study	13
Low-dose IL-2 therapy limits the reduction in absolute numbers of circulating regulatory T cells in rheumatoid arthritis	12
Prognostic factors for 1-year functional outcome, quality of life, care demands, and mortality after surgery in Taiwanese geriatric patients with a hip fracture: a prospective cohort study	12
Prevalence, therapy and tumour response in patients with rheumatic immune-related adverse events following immune checkpoint inhibitor therapy: a single-centre analysis	12
Bronchoalveolar lavage and lung biopsy in connective tissue diseases, to do or not to do?	12
Cell-based therapies for rheumatoid arthritis: opportunities and challenges	11
Prevalence and characteristics of giant cell arteritis in patients with newly diagnosed polymyalgia rheumatica – a prospective cohort study	11
Back pain treatment: a new perspective	11
Associations between glucocorticoids, antiphospholipid antibodies and femur head necrosis in patients with SLE: a directed acyclic graph-based multicentre study	11
Circulating microRNAs differentiate fast-progressing from slow-progressing and non-progressing knee osteoarthritis in the Osteoarthritis Initiative cohort	11
Reduction of anterior uveitis flares in patients with axial spondyloarthritis on certolizumab pegol treatment: final 2-year results from the multicenter phase IV C-VIEW study	11
Diagnosis and management of lung involvement in systemic lupus erythematosus and Sjögren’s syndrome: a literature review	11
Age-stratified trends in the progression of spinal radiographic damage in patients with ankylosing spondylitis: a longitudinal study	10
Sjögren syndrome: looking forward to the future	10
Bone fragility during the COVID-19 pandemic: the role of macro- and micronutrients	10
Update on the therapy of adult-onset Still’s disease with a focus on IL-1-inhibition: a systematic review	10
Biomarkers for interstitial lung disease and acute-onset diffuse interstitial lung disease in rheumatoid arthritis	10
Mesenchymal stromal cell products for intra-articular knee injections for conservative management of osteoarthritis	10
Looking ahead: giant-cell arteritis in 10 years time	10
Gastrointestinal involvement and its association with the risk for nephritis in IgA vasculitis	10
Intra-articular placebo effect in the treatment of knee osteoarthritis: a survey of the current clinical evidence	9
Viscosupplementation for the treatment of osteoarthritis. The contribution of EUROVISCO group	9
Secukinumab in axial spondyloarthritis: a narrative review of clinical evidence	9
A glance into the future of gout	9
Limiting factors to Boolean remission differ between autoantibody-positive and -negative patients in early rheumatoid arthritis	9
Health disparities in rheumatoid arthritis	9
Interactions of the microbiome with pharmacological and non-pharmacological approaches for the management of ageing-related musculoskeletal diseases	9
Prevalence and risk factors of moderate to severe hepatic steatosis in patients with rheumatoid arthritis: an ultrasonography cross-sectional case–control study	9
Real-world evidence to assess the effectiveness of platelet-rich plasma in the treatment of knee degenerative pathology: a prospective observational study	9
Soluble biological markers in osteoarthritis	9
Association of C-reactive protein and non-steroidal anti-inflammatory drugs with cardiovascular events in patients with psoriatic arthritis: a time-dependent Cox regression analysis	8
Osteopathic medicine for fibromyalgia: a sham-controlled randomized clinical trial	8
Managing inadequate response to initial anti-TNF therapy in rheumatoid arthritis: optimising treatment outcomes	8
Cardiovascular risk in patients with spondyloarthritis and association with anti-TNF drugs	8
Efficacy and safety of biologic agents for the treatment of osteoarthritis: a meta-analysis of randomized placebo-controlled trials	8
Inequities in people with gout: a focus on Māori (Indigenous People) of Aotearoa New Zealand	8
The importance of maternal pregnancy vitamin D for offspring bone health: learnings from the MAVIDOS trial	8
Future challenges in rheumatology – is telemedicine the solution?	8
A comparison of clinical examination and ultrasound enthesitis indices in patients with psoriatic arthritis, adjusted for concomitant fibromyalgia	8
Clinical and immunological study of Tofacitinib and Baricitinib in refractory Blau syndrome: case report and literature review	8
Increased risk of valvular heart disease in patients with ankylosing spondylitis: a nationwide population-based longitudinal cohort study	8
Autologous stem-cell transplantation in systemic sclerosis-associated interstitial lung disease: early action in selected patients rather than escalation therapy for all	8
The current state of the osteoarthritis drug development pipeline: a comprehensive narrative review of the present challenges and future opportunities	8
Stromal vascular fraction therapy for knee osteoarthritis: a systematic review	8
Wearable transcutaneous electrical nerve stimulation (actiTENS®) is effective and safe for the treatment of knee osteoarthritis pain: a randomized controlled trial versus weak opioids	8
Epidemiology and risk of invasive fungal infections in systemic lupus erythematosus: a nationwide population-based cohort study	8

Presence of anti-acetylated peptide antibodies (AAPA) in inflammatory arthritis and other rheumatic diseases suggests discriminative diagnostic capacity towards early rheumatoid arthritis	8
Sarcopenia and bone health: new acquisitions for a firm liaison	7
A glance into the future of diagnosis and treatment of spondyloarthritis	7
The role of antifibrotics in the treatment of rheumatoid arthritis–associated interstitial lung disease	7
Distribution of comorbidities in spondyloarthritis with regard to the phenotype and psoriasis: data from the ASAS-COMOSPA study	7
Tocilizumab in refractory Caucasian Takayasu’s arteritis: a multicenter study of 54 patients and literature review	7
Latest insights in disease-modifying osteoarthritis drugs development	7
Open questions on the management of targeted therapies for the treatment of systemic sclerosis-interstitial lung disease: results of a EUSTAR survey based on a systemic literature review	7
Ten-year survival analysis of patients with primary Sjögren’s syndrome in China: a national prospective cohort study	7
Factors associated with risk of major adverse cardiovascular events in patients with rheumatoid arthritis: a nationwide, population-based, case-control study	7
New insights on multigenic autoinflammatory diseases	7
RETRACTED: Cyclin-dependent kinase 7 (CDK7) is an emerging prognostic biomarker and therapeutic target in osteosarcoma	7
Safety and efficacy of SHR4640 combined with febuxostat for primary hyperuricemia: a multicenter, randomized, double-blind, phase II study	6
The sonographic identification of cortical bone interruptions in rheumatoid arthritis: a morphological approach	6
Repurposing haloperidol for the treatment of rheumatoid arthritis: an integrative approach using data mining techniques	6
Digital health interventions for osteoporosis and post-fragility fracture care	6
Ultrasonography predicts the results of labial salivary gland biopsy in patients with suspected Sjögren’s syndrome: a matrix risk model	6
Person-centered versus body-centered approaches in osteopathic care for chronic pain conditions	6
Tocilizumab in visual involvement of giant cell arteritis: a multicenter study of 471 patients	6
Impact of immunogenicity on clinical efficacy and toxicity profile of biologic agents used for treatment of inflammatory arthritis in children compared to adults	6
Autologous hematopoietic stem cell transplantation modifies specific aspects of systemic sclerosis-related microvasculopathy	6
A pilot study on deep learning-based grading of corners of vertebral bodies for assessment of radiographic progression in patients with ankylosing spondylitis	6
Baricitinib in the treatment of rheumatoid arthritis: clinical and ultrasound evaluation of a real-life single-centre experience	6
Influence of colchicine prescription in COVID-19-related hospital admissions: a survival analysis	6
Consensus evidence-based recommendations for treat-to-target management of immunoglobulin A vasculitis	6
Role of antifibrotics in the management of idiopathic inflammatory myopathy associated interstitial lung disease	6
Sustained clinical response and safety of etanercept in patients with early axial spondyloarthritis: 10-year results of the ESTHER trial	6
The association of depression and anxiety with treatment outcomes in patients with rheumatoid arthritis – a pooled analysis of five randomised controlled trials	6
Association between bone trace elements and osteoporosis in older adults: a cross-sectional study	6
A theoretical framework to improve the construct for chronic pain disorders using fibromyalgia as an example	6
Risk factors for symptomatic vascular events in giant cell arteritis: a study of 254 patients with large-vessel imaging at diagnosis	6
Higher body mass index is associated with a lower iloprost infusion rate tolerance and higher iloprost-related adverse events in patients with systemic sclerosis	5
Validation of the ASDAS with a quick quantitative CRP assay (ASDAS-Q) in patients with axial SpA: a prospective multicentre cross-sectional study	5
Association of anti-thyroid antibodies with radiographic knee osteoarthritis and chondrocalcinosis: a NHANES III study	5
Normal C-reactive protein in active psoriatic arthritis: results from real-world clinical practice	5
Prescription strategy of antimalarials in cutaneous and systemic lupus erythematosus: an international survey	5
Characterization of disease course and remission in early seropositive rheumatoid arthritis: results from the TACERA longitudinal cohort study	5
Predicting osteoarthritis in adults using statistical data mining and machine learning	5
Update on the therapeutic management of patients with either psoriatic arthritis or ulcerative colitis: focus on the JAK inhibitor tofacitinib	5
Immunomodulation with IL-17 and TNF-α in spondyloarthritis: focus on the eye and the central nervous system	5
Validation of the 2019 EULAR/ACR classification criteria for systemic lupus erythematosus in ANA-positive Chinese patients	5
Switching from originator adalimumab to biosimilar SB5 in a rheumatology cohort: persistence on treatment, predictors of drug interruption and safety analysis	5
Potential relation of cardiovascular risk factors to disease activity in patients with axial spondyloarthritis	5
Osteosarcopenia and Long-COVID: a dangerous combination	5
Big data analyses and individual health profiling in the arena of rheumatic and musculoskeletal diseases (RMDs)	5
Interstitial lung disease pathology in systemic sclerosis	5
Impact of sarcopenia on rehabilitation outcomes after total knee replacement in older adults with knee osteoarthritis	4
Early knee OA definition–what do we know at this stage? An imaging perspective	4
Comparison of healthcare resource utilization and medical costs between patients with seropositive and seronegative rheumatoid arthritis	4
Based on minimal clinically important difference values, a moderate dose of tanezumab may be a better option for treating hip or knee osteoarthritis: a meta-analysis of randomized controlled trials	4
Potential complementary and/or synergistic effects of curcumin and boswellic acids for management of osteoarthritis	4
An update on the use of conventional and biological disease-modifying anti-rheumatic drugs in hand osteoarthritis	4
Latest advancements in imaging techniques in OA	4
Intervertebral disc therapies for non-specific chronic low back pain: a systematic review and meta-analysis	4
Bone fragility: conceptual framework, therapeutic implications, and COVID-19-related issues	4
Plasma calprotectin as a biomarker of ultrasound synovitis in rheumatoid arthritis patients receiving IL-6 antagonists or JAK inhibitors	4
Pregnancy in juvenile idiopathic arthritis: maternal and foetal outcome, and impact on disease activity	4
Effectiveness and safety of secukinumab in axial spondyloarthritis: a 24-month prospective, multicenter real-life study	4
Early anti IL-1 treatment replaces steroids in refractory Kawasaki disease: clinical experience from two case reports	4
Nutritional and physical activity issues in frailty syndrome during the COVID-19 pandemic	4
The application of machine learning in early diagnosis of osteoarthritis: a narrative review	4
Psoriatic arthritis: prospects for the future	4
Future projections of opioid use and cost in patients with chronic osteoarthritis pain in Spain	4
Rehabilitation of the face and temporomandibular joint in systemic sclerosis	4
Poor health and functioning in patients with axial spondyloarthritis during the COVID-19 pandemic and lockdown: REUMAVID study (phase 1)	4